SECTOR NEWS CONSUMER 🔸 $STZ: Q4 EPS $2.63 (est. $2.29); sales +1.2% to $2.16B (est. $2.13B). Beer sales in line, wine/spirits beat. Selling mainstream wine brands to The Wine Group. FY28 EPS growth seen low to mid-single digits. New $4B buyback plan. 🔸 $GM: Downgraded to Neutral from Buy at UBS; target cut to $51 from $64 due to tariff impact. 🔸 $KMX: Q4 EPS $0.58 (est. $0.65); retail used sales +6.2%, comps +5.1%, wholesale units +3.1%. Revenue $6.0B (est. $5.963B). 🔸 $PSMT: Q2 EPS $1.45 (est. $1.40); sales $1.335B (est. $1.359B); comps +6.7%. 🔸 $BKE: March comps +3.7%, net sales +4.5% to $109.1M. ENERGY, INDUSTRIALS & MATERIALS 🔸 $X: Shares fell after Trump opposed Nippon Steel’s takeover. 🔸 $VALE: Upgraded to Buy at Bank of America. FINANCIALS 🔸 $AB: AUM fell to $784B in March from $805B in Feb. 🔸 $CBOE: Downgraded to Neutral at Bank of America. 🔸 $LAZ: March AUM $227.4B; net outflows $3.1B, market loss $5.4B. 🔸 $VCTR: Total client assets $171.4B as of March. HEALTHCARE 🔸 $IDYA: Started Phase 1/2 expansion trial combining IDE397 with Gilead’s Trodelvy. 🔸 $KROS: Shares rise after adopting poison pill; exploring strategic options, including sale. TECHNOLOGY, MEDIA & TELECOM 🔸 $AMZN: 2024 revenue +11% to $638B; AWS +19% to $108B; operating income +86% to $68.6B. 🔸 $ASYS: Cuts Q2 revenue forecast to $15M–$16M (from $21M–$23M) due to customer dispute. 🔸 $TSM: Q1 sales +42% to $25.6B, in line with guidance despite earthquake impact.

STOCKS ON THE MOVE $ONCO, up 82.4% $CNEY, up 57.8% $BMY: up 4.4% premarket, Gains as FDA approves its schizophrenia drug China ADRs extend their rally on latest stimulus push $BABA: up 0.4% premarket $JD: up 2.6% premarket $PDD, up 1.33% premarket $LI: up 0.4% premarket $SAVA: down 11.7% premarket, after SEC charges co for misleading Alzheimer's drug trial claims $COST: down 1.0% premarket, after Q4 results; brokerages hike PT $DG: down 2.5% premarket, Citi downgrades Dollar General citing tough sales recovery as Walmart takes market share $ESTA: up 27.3% premarket, on US FDA nod for Motiva breast implants $KMX: up 0.7% premarket, Brokerages raise Carmax PT on expectations of recovery in US used car market $WVE: up 2.2% premarket, JP Morgan resumes coverage with 'overweight' $IONQ: up 8.1% premarket, Gains on $54.5 mln contract with US Air Force Research Lab $BMBL: down 2.2% premarket, Down after KeyBanc downgrades to 'sector weight'